NSC |
Compound |
Enrichment |
Correlation |
NSC 740 |
Methotrexate |
0.0228801759885687 |
0.26185264 |
NSC 740476 |
Null |
0.0228801759885687 |
0.14770015 |
NSC 743876 |
Null |
0.0228801759885687 |
0.24729933 |
NSC 746053 |
Null |
0.0228801759885687 |
0.32069244 |
NSC 746540 |
Null |
0.0228801759885687 |
0.45148414 |
NSC 758119 |
(1R,6S,11aS,13S,14aR)-1,13-dihydroxy-6-vinyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-4-one |
0.0228801759885687 |
0.045632357 |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0228801759885687 |
0.19562273 |
NSC 89074 |
Thiosulfuric acid (H2S2O3), -[2-[(5-cyclohexylpentyl)amino]ethyl] ester (9CI) |
0.0228801759885687 |
0.28760197 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0238174255956147 |
0.43287554 |
NSC 132313 |
Dianhydrogalactitol |
0.0238174255956147 |
0.05877898 |